Results 21 to 30 of about 22,651 (250)
Second Primary Malignancies in Patients With Hepatocellular Carcinoma: A Population-Based Analysis
BackgroundSecond primary malignancy (SPM) is becoming a threat for the health of cancer survivors. However, data on the features and results of patients with hepatocellular carcinoma (HCC) with SPMs are scarce.
Junjie Kong +9 more
doaj +1 more source
HerMeS: a registry-based evaluation of the HERCULES criteria for identifying nonrelapsing SPMS. [PDF]
Background: Secondary progressive multiple sclerosis (SPMS) encompasses heterogeneous phenotypes that may or may not exhibit disease activity. Objectives: To characterize a cohort of non-relapsing SPMS (nrSPMS) identified through a data-driven ...
Guerra T +40 more
europepmc +3 more sources
The solid solution [Pb(Yb1/2Nb1/2)O3]1−x-[PbTiO3]x was synthesized with x≤60%, using several high-temperature techniques as well as room-temperature mechanosynthesis. The high-temperature synthesis reveals a reaction path involving the synthesis first of
Charlotte Cochard +4 more
doaj +1 more source
Background and Aims Transition to secondary progressive multiple sclerosis (SPMS) from relapsing‐remitting MS (RRMS) is an expected part of the disease trajectory for most patients.
Sophie Clare Laura Caseby +4 more
doaj +1 more source
The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study. [PDF]
BACKGROUND:Head and neck cancer (HNC) is associated with a high rate of developing second primary malignancies(SPMs). But the impact on survival remains poorly understood before. Therefore, we want to estimate the impact of SPMs on HNC survivors. METHODS
Li-Jen Liao +4 more
doaj +1 more source
Th17 cells increase in RRMS as well as in SPMS, whereas various other phenotypes of Th17 increase in RRMS only. [PDF]
Background: The nature and extent of inflammation seen in multiple sclerosis (MS) varies throughout the course of the disease. Changes seen in CD4+ T-helper cells in relapsing-remitting (RR) MS and secondary progressive (SP) MS might differ qualitatively
core +1 more source
Selective DNAM-1 expression on small peritoneal macrophages contributes to CD4+ T cell costimulation
Mouse peritoneal macrophages consist of two subsets: large peritoneal macrophages (LPMs) and small peritoneal macrophages (SPMs), defined as CD11bhiF4/80hi and CD11b+F4/80lo cells, respectively.
Eri Takenaka +4 more
doaj +1 more source
Can we treat secondary progressive multiple sclerosis now?
Secondary progressive multiple sclerosis (SPMS) is characterized by progressive accumulation of disability without intermittent recovery. Treatment of these patients is challenging due to limited understanding of pathogenesis and fewer therapeutic ...
Rohit Bhatia, Nishita Singh
doaj +1 more source
Results for variable number of SPMs.
Results for variable number of SPMs.
Yuzhong Li (738973) +2 more
core +1 more source
Structural signature in Stokes-shifted broad emission of solution-processed hybrid lead perovskites
Understanding the emission process of Stokes-shifted broad photoluminescence (PL) in HOIPs is important for both fundamental science and applications. We present here results of temperature-dependent PL, X-ray diffraction, and Raman studies of solution ...
Subhadip Chowdhury +3 more
doaj +1 more source

